Akers Biosciences: Notice of Preliminary Results | Company Announcements

Wednesday 11 March, 2009

Akers Biosciences

Notice of Preliminary Results

RNS Number : 6468O

Akers Biosciences, Inc.

11 March 2009

Akers Biosciences, Inc.

Notice of Preliminary Results

Akers Biosciences, Inc. (AIM:AKR), a leading designer and manufacturer of rapid diagnostic screening and testing products, announces that it will publish results for the year ended 31 December 2008 on Tuesday, 24 March 2009.

For further information please contact:

Thomas A. Nicolette

President and CEO

Tel. +1 856 848 8698

Ben Simons

M: Communications

Tel. +44 (0)20 7153 1540

Alasdair Younie

Arbuthnot Securities Limited

Tel. +44 (0)20 7012 2000

This information is provided by RNS

The company news service from the London Stock Exchange

END

NORBRGDXLBBGGCG

Investegate takes no responsibility for the accuracy of the information within the site.

The announcements are supplied by the denoted source. Queries about the content of an announcement should be directed to the source. Investegate reserves the right to publish a filtered set of announcements. NAV, EMM/EPT, Rule 8 and FRN Variable Rate Fix announcements are filitered from this site.